Ketamine Does Not Produce Relief of Neuropathic Pain in Mice Lacking the β-Common Receptor (CD131)

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Swartjes, Maarten ^a   Niesters, Marieke ^a   Heij, Lara ^a   Dunne, Ann ^b   Aarts, Leon ^a   Hand, Carla Cerami ^c   Kim, Hyung Suk ^c   Brines, Michael ^b   Cerami, Anthony ^a,b   Dahan, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ARAIM PHARMACEUTICALS   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ARA 290; CD131 ANTIGEN; KETAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; ASTROCYTE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; LIGAND BINDING; MICROGLIA; MOUSE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ANIMAL; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; FEMALE; GENE KNOCKOUT TECHNIQUES; KETAMINE; MICE; MICE, INBRED C57BL; NEURALGIA; NOCICEPTION; OLIGOPEPTIDES; RNA, MESSENGER; SPINAL CORD;

EID: 84881000526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071326     Document Type: Article

References (35)

1. Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, et al. (2008) Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70: 1630-1635.
2. Costigan M, Scholz J, Woolf CJ, (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32: 1-32.
3. Tavee J, Zhou L, (2009) Small fiber neuropathy: A burning problem. Cleve Clin J Med 76: 297-305.
4. Calvo M, Dawes JM, Bennett DL, (2012) The role of the immune system in the generation of neuropathic pain. Lancet Neurol 11: 629-642.
5. Lipton SA, (2004) Erythropoietin for neurologic protection and diabetic neuropathy. N Engl J Med 350: 2516-2517.
6. Sekiguchi Y, Kikuchi S, Myers RR, Campana WM, (2003) Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush. Spine 28: 2577-2584.
7. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proc Natl Acad Sci USA 101: 14907-14912.
8. Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, et al. (2012) The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol Rev 250: 277-302.
9. Brines M, Cerami A, (2012) The receptor that tames the innate immune response. Mol Med 18: 486-496.
10. Swartjes M, Morariu A, Niesters M, Brines M, Cerami A, et al. (2011) ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain. An experimental study in rats and b-common receptor knockout mice. Anesthesiology 115: 1084-1092.
11. Heij L, Niesters M, Swartjes M, Hoitsma E, Drent M, et al. (2013) Safety and efficacy of ARA290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double blind, pilot study. Mol Med 18: 1430-1436.
12. Niesters M, Swartjes M, Heij L, Brines M, Cerami A, et al. (2012) The erythropoietin analog ARA 290 for treatment of sarcoidosis-induced chronic neuropathic pain. Expert Opin Orphan Drugs 1: 77-87.
13. Noppers I, Niesters M, Aarts L, Smith T, Sarton E, et al. (2010) Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother 2010 11: 2417-2429.
14. Niesters M, Dahan A, (2012) Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain. Expert Opin Drug Metab Toxicol 8: 1409-1417.
15. Sigtermans M, van Hilten JJ, Bauer M, Arbous M, Marinus J, et al. (2009) Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 145: 304-311.
16. Hayashi Y, Kawaji K, Sun L, Zhang X, Koyano K, et al. (2011) Microglial Ca2+-activated K+ channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. Journal Neurosci 31: 17370-17382.
17. Mei XP, Zhang H, Wang W, Wei YY, Zhai MZ, et al. (2011) Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain. J Neuroinflammation 8: 6.
18. Sacca R, Engle SJ, Qin W, Stock JL, McNeish JD. Genetically engineered mouse models in drug discovery research. Meth Mol Biol 602: 37-54.
19. Zimmermann M, (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
20. Robb L, Drinkwater CC, Metcalf D, Li R, Köntgen F, et al. (1995) Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 92: 9565-9569.
21. Kim HS, Lee G, John SWM, Maeda N, Smithies O, (2002) Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration. Proc Natal Acad Sci USA 99: 4602-4607.
22. Swartjes M, Morariu A, Niesters M, Aarts L, Dahan A, (2011) Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology 115: 165-174.
23. Wang S, Lim G, Zeng Q, Sung B, Yang L, et al. (2005) Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 25: 488-495.
24. Labombarda F, Coronel MF, Villar MJ, Nicola AFD, González SL, (2008) Neuropathic pain and temporal expression of preprodynorphin, protein kinase C and N-methyl-D-aspartate receptor subunits after spinal cord injury. Neurosci Lett 447: 115-119.
25. Wilson JA, Garry EM, Anderson HA, Rosie R, Colvin LA, et al. (2005) NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists. Pain 117: 421-432.
26. Erichsen HK, Blackburn-Munro G, (2002) Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 98: 151-161.
27. Zhuang ZY, Gerner P, Woolf CJ, Ji RR, (2005) ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114: 149-159.
28. Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, Mauborgne A, Dansereau MA, et al. (2011) CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve Injury. J Neurosci 31: 5865-5875.
29. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, et al. (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106: 757-769.
30. Takahashi T, Kinoshita M, Shono S, Habu Y, Ogura T, et al. (2010) The effect of ketamine anesthesia on the immune function of mice with postoperative septicemia. Anesth Analg 111: 1051-1058.
31. Brines M, Patel NSA, Villa P, Brines C, Mennini T, et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natal Acad Sci USA 105: 10925-10930.
32. Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA, (2006) The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism. Neuropharmacology 51: 12-17.
33. Cohen ML, Chan SL, Way WL, Trevor AJ, (1973) Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39: 370-376.
34. Arsenault A, Sawynok J, (2009) Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury. Pain 146: 308-314.
35. Loix S, De Kock M, Henin P, (2011) The anti-inflammatory effects of ketamine: state of the art. Acta Anaesthesiol Belg 62: 47-58.